Description: Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a specialty pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide. The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric. It has collaboration and licensing agreement with Sulfateq BV for the development and commercialization of the original molecule SUL-238 as a unique treatment for Alzheimer's disease and other neurodegenerative diseases. The company was incorporated in 1997 and is headquartered in Çankaya, Turkey.
Home Page: www.genilac.com.tr
Mustafa Kemal Mahallesi 2119.Sk. No:3
Çankaya,
06520
Turkey
Phone:
90 312 219 62 19
Officers
| Name | Title |
|---|---|
| Mr. Abidin Gulmus | Chairman & GM |
| Semra Gulmus | Founder |
| Dr. Deniz Karagulle | Assistant Gen. Mang. of Sales & Marketing |
| Yagmur Selin Gulmus Kolay | Assistant Gen. Mang. of Strategy & Corp. Devel. |
Exchange: IS
Country: TR
Currency: Turkish lira (₺)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 27.1552 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 576 |